Treatment of recurrent hepatitis C following liver transplantation

被引：4

作者：

Bizollon T. ^{[1
]}

Ducerf C. ^{[1
]}

Baulieux J. ^{[1
]}

Trepo C. ^{[1
]}

机构：

[1] Hepatology Unit, Hotel-Dieu, Lyon Cedex 02

来源：

Current Gastroenterology Reports | 1999年 / 1卷 / 1期

关键词：

Cholestatic Hepatitis; Follow Liver Transplantation; Liver Transplant Recipient; Liver Transplantation; Orthotopic Liver Transplantation;

D O I：

10.1007/s11894-999-0081-8

中图分类号：

学科分类号：

摘要：

Cirrhosis due to hepatitis C virus infection is now the most common indication for liver transplantation in Western Europe and the United States. In the absence of effective prophylaxis, recurrent hepatitis C virus infection is almost inevitable. Although the natural history and intermediateterm outcome of recurrent infection with hepatitis C virus are now better documented, factors that may influence the recurrence of hepatitis and consequent progression of graft disease remain unclear. Interferon used as a single agent for the treatment of recurrent infection has proven unsatisfactory. Early intervention for recurrent infection with the combination of interferon and ribavirin appears promising, and this approach may prevent or delay progression of hepatitis C virus-related graft disease after liver transplantation. © 1999, Current Science Inc.

引用

页码：15 / 19

页数：4

共 35 条

[1]

Kuo, G., Choo, Q.L., Alter, H.J., An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis (1989) Science, 244, pp. 362-364. , PID: 2496467, COI: 1:CAS:528:DyaL1MXit12lu7w%3D

[2]

Di Bisciglie, A.M., Goodmann, Z.D., Ishak, K.G., Long term clinical and histopathological follow up of chronic posttransfusion hepatitis (1991) Hepatology, 14, pp. 969-974

[3]

Di Bisciglie, A.M., Hepatitis C and hepatocellular carcinoma (1995) Semin Liver Dis, 15, pp. 64-69

[4]

Tine, F., Magin, S., Craxi, A., Interferon for non-A, non-B chronic hepatitis: a meta-analysis of randomised clinical trials (1991) J Hepatol, 13, pp. 192-199. , PID: 1835989, COI: 1:STN:280:DyaK38%2FnvVKhuw%3D%3D

[5]

Ascher, N.L., Lake, J.R., Emond, J., Liver transplantation for hepatitis C virus-related cirrhosis: consensus conference on indications of liver transplantation (1994) Hepatology, 20, pp. 24S-27S. , PID: 8005575, COI: 1:STN:280:DyaK2c3nsVWrtw%3D%3D

[6]

European Liver Transplant Registry (1994) Villejuif, France: Centre Hépato-Biliaire, Hopital Paul Brousse, p. 1994. , June

[7]

Bizollon, T., Mutimer, D., Ducerf, C., Trepo, C., Hepatitis C virus recurrence after liver transplantation (1998) Gut, , in press

[8]

Weiner, A.J., Brauer, M.J., Rosenblatt, J., Variable and hypervariable domains are found in the region of HVC corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins (1991) Virology, 180, pp. 842-848. , PID: 1846505, COI: 1:CAS:528:DyaK3MXhtFGqtrw%3D

[9]

Chazouilleres, O., Kim, M., Combs, C., Quantitation of hepatitis C virus RNA in liver transplant recipients (1994) Gastroenterology, 106, pp. 994-999. , PID: 8144005, COI: 1:STN:280:DyaK2c7pt12ktw%3D%3D, This study shows the absence of relationship between posttransplantation levels of HCV RNA and the degree of histologic liver damage

[10]

Ferrell, L., Wright, T.L., Roberts, J., Hepatitis C viral infection in liver transplant recipients (1992) Hepatology, 16, pp. 865-876. , PID: 1383115, COI: 1:STN:280:DyaK3s%2FhtlGgtw%3D%3D

← 1 2 3 4 →